Fabio earned his M.Sc. in Medical and Pharmaceutical Biotechnology from the University of Pavia in 2017. During this time, he gained valuable experience as a bioinformatician at enGenome, a spin-off of the University of Pavia. He then completed his Ph.D. in Health Biology: Genomics and Bioinformatics at Aix-Marseille University in February 2022.

Before joining Humanitas, Fabio held research positions at prestigious international institutions. From 2018 to 2019, he served as a bioinformatics engineer at the French National Center for Scientific Research (CNRS) with the Muscle Dynamics group led by Frank Schnorrer, applying multi-omics approaches to study muscle morphogenesis and sarcopenic diseases such as muscular dystrophy. Since 2019, he has been a member of the Computational Biology team at the Marseille Developmental Biology Institute (IBDM), led by Bianca Habermann, focusing on mitochondria and their role in pathological conditions. During this tenure, he conducted multi-omics analyses encompassing transcriptomics, proteomics, and epigenomics, and developed two integrative multi-omics web platforms: AnnoMiner and mitoXplorer. Fabio has collaborated extensively with renowned research teams including Bart Deplancke’s group at EPFL (Lausanne) and Olivier Pourquié’s team at Harvard Medical School (Boston).

In July 2024, Fabio joined the Computational Biology Lab at Humanitas Research Hospital in Rozzano (Italy), under the leadership of Professor C.K.Y. Ng. His current research focuses on elucidating the molecular mechanisms driving cancer development and progression. Fabio utilizes genomic and bioinformatic approaches to advance precision oncology, particularly in integrating multi-omics data to identify prognostic and predictive biomarkers for various cancers.